JOHN BELMONT to Adenosine Deaminase
This is a "connection" page, showing publications JOHN BELMONT has written about Adenosine Deaminase.
Connection Strength
0.702
-
Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J Exp Med. 1991 Oct 01; 174(4):837-45.
Score: 0.096
-
Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector. Hum Gene Ther. 1991; 2(4):307-15.
Score: 0.091
-
Human adenosine deaminase expression in mice. Blood. 1990 May 15; 75(10):2085-92.
Score: 0.087
-
Expression vectors for human adenosine deaminase gene therapy. Genome. 1989; 31(2):832-9.
Score: 0.079
-
Expression of human adenosine deaminase in murine hematopoietic cells. Mol Cell Biol. 1988 Dec; 8(12):5116-25.
Score: 0.079
-
Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer. Nature. 1986 Jul 24-30; 322(6077):385-7.
Score: 0.067
-
Towards gene therapy for adenosine deaminase deficiency. Ann Clin Res. 1986; 18(5-6):322-6.
Score: 0.064
-
Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci U S A. 1995 Apr 25; 92(9):3673-7.
Score: 0.031
-
Delivery of a secretable adenosine deaminase through microcapsules--a novel approach to somatic gene therapy. Hum Gene Ther. 1994 Dec; 5(12):1445-55.
Score: 0.030
-
Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells. Hum Gene Ther. 1991; 2(3):203-13.
Score: 0.023
-
Effects of leukemia inhibitory factor (LIF) on gene transfer efficiency into murine hematolymphoid progenitors. Adv Exp Med Biol. 1991; 292:131-8.
Score: 0.023
-
Human gene expression in murine hemopoietic cells in vivo. Adv Exp Med Biol. 1988; 241:123-7.
Score: 0.018
-
Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines. Virology. 1991 Feb; 180(2):849-52.
Score: 0.006
-
Gene therapy: a new approach for the treatment of genetic disorders. Clin Pharmacol Ther. 1990 Jan; 47(1):1-11.
Score: 0.005
-
Gene replacement therapy for inborn errors of purine metabolism. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:1065-71.
Score: 0.004